# Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis

Study · id `cardio:ct-nct07612124` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07612124](<https://clinicaltrials.gov/study/NCT07612124>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07612124

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.

## Technical summary

Registry record NCT07612124. Randomized; no masking; primary purpose health services research. Start 2024-07-01 (actual); primary completion 2025-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 223 participants (enrolled count; ClinicalTrials.gov record NCT07612124, source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)
- Started: 2024-07-01 (actual) (ClinicalTrials.gov record NCT07612124, source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (actual) (ClinicalTrials.gov record NCT07612124, source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)
- Completion: 2026-04-01 (actual) (ClinicalTrials.gov record NCT07612124, source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07612124, source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07612124-2026-05-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis
- Condition: Kidney Failure Chronic
- Condition: ESRD (End-Stage Renal Disease)
- Intervention (Other): Conventional Follow-up
- Intervention (Device): Weiyin Health Smart Application
- Lead sponsor: The Third Xiangya Hospital of Central South University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: The Third Xiangya Hospital of Central South University (`cardio:org-the-third-xiangya-hospital-of-central-south-university`)

## Provenance

Content hash: bb905f1a0b31aad75d873dc82b34a94e703cf03a5e7be80a6d035d36140e2ada
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
